Statistical analysis The data were analyzed using SPSS software (version 17.0, Chicago, IL.) Independent t-tests were employed to examine the difference in anthropometrics, biochemical characteristics, obesity-related hormone peptides, and life-quality scores between EGCG group and placebo group
All cases resolved after stopping the medication
Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns
These antibodies bind to ECs and induce apoptosis, contributing to tissue damage (Fig
Gawad Estudio HOST-BR ACC Congress 2025 Chicago EMPULSE: empagliflozina en insuficiencia cardiaca aguda Estudio CHAMPION-AF ACC 2026 Nueva Orleans Estudio FRESH-UP ACC Congress 2025 Chicago Heart Failure with Preserved Ejection Fraction By DR
doi:10.3233/JAD-142814
